231 related articles for article (PubMed ID: 37284636)
1. Hypothesis: Entrapment of lipoprotein particles in the brain causes Alzheimer's disease.
Boche D; Nicoll JA
Free Neuropathol; 2021 Jan; 2():. PubMed ID: 37284636
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.
Poirier J
Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of apolipoproteins from murine microglia. Identification of a low density lipoprotein-like apolipoprotein J-rich but E-poor spherical particle.
Xu Q; Li Y; Cyras C; Sanan DA; Cordell B
J Biol Chem; 2000 Oct; 275(41):31770-7. PubMed ID: 10918055
[TBL] [Abstract][Full Text] [Related]
4. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
[TBL] [Abstract][Full Text] [Related]
5. A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.
Sawmiller D; Habib A; Hou H; Mori T; Fan A; Tian J; Zeng J; Giunta B; Sanberg PR; Mattson MP; Tan J
Biol Psychiatry; 2019 Aug; 86(3):208-220. PubMed ID: 31208706
[TBL] [Abstract][Full Text] [Related]
6. APOE and Alzheimer's Disease: From Lipid Transport to Physiopathology and Therapeutics.
Husain MA; Laurent B; Plourde M
Front Neurosci; 2021; 15():630502. PubMed ID: 33679311
[TBL] [Abstract][Full Text] [Related]
7. HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer's Disease Pathogenesis.
Borràs C; Mercer A; Sirisi S; Alcolea D; Escolà-Gil JC; Blanco-Vaca F; Tondo M
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012637
[TBL] [Abstract][Full Text] [Related]
8. ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Aβ production independently of their cholesterol efflux capacity.
Dafnis I; Raftopoulou C; Mountaki C; Megalou E; Zannis VI; Chroni A
Biochem J; 2018 May; 475(10):1839-1859. PubMed ID: 29743204
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele.
Padayachee ER; Zetterberg H; Portelius E; Borén J; Molinuevo JL; Andreasen N; Cukalevski R; Linse S; Blennow K; Andreasson U
Brain Res; 2016 Nov; 1651():11-16. PubMed ID: 27653981
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid lipoprotein delivery to human neuronal cells is increased in Alzheimer's disease and is dependent on apoE monomer concentration.
Bassett CN; Swift LL; Montine KS; Markesbery WR; Montine TJ
J Alzheimers Dis; 2002 Feb; 4(1):19-30. PubMed ID: 12214015
[TBL] [Abstract][Full Text] [Related]
11. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease.
Zhao N; Liu CC; Qiao W; Bu G
Biol Psychiatry; 2018 Feb; 83(4):347-357. PubMed ID: 28434655
[TBL] [Abstract][Full Text] [Related]
13. Peripheral metabolism of lipoprotein-amyloid beta as a risk factor for Alzheimer's disease: potential interactive effects of APOE genotype with dietary fats.
D'Alonzo ZJ; Lam V; Takechi R; Nesbit M; Vaccarezza M; Mamo JCL
Genes Nutr; 2023 Feb; 18(1):2. PubMed ID: 36841786
[TBL] [Abstract][Full Text] [Related]
14. Functional role of lipoprotein receptors in Alzheimer's disease.
Jaeger S; Pietrzik CU
Curr Alzheimer Res; 2008 Feb; 5(1):15-25. PubMed ID: 18288927
[TBL] [Abstract][Full Text] [Related]
15. Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk.
Takechi R; Galloway S; Pallebage-Gamarallage MM; Lam V; Mamo JC
Prog Lipid Res; 2010 Apr; 49(2):159-70. PubMed ID: 19896503
[TBL] [Abstract][Full Text] [Related]
16. Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis.
Carter CJ
Neurochem Int; 2007 Jan; 50(1):12-38. PubMed ID: 16973241
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease amyloid-beta peptide modulates apolipoprotein E isoform specific receptor binding.
Hone E; Martins IJ; Jeoung M; Ji TH; Gandy SE; Martins RN
J Alzheimers Dis; 2005 Aug; 7(4):303-14. PubMed ID: 16131732
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
19. Role of cholesterol in amyloid cascade: cholesterol-dependent modulation of tau phosphorylation and mitochondrial function.
Michikawa M
Acta Neurol Scand Suppl; 2006; 185():21-6. PubMed ID: 16866907
[TBL] [Abstract][Full Text] [Related]
20. Endogenous Apolipoprotein E (ApoE) Fragmentation Is Linked to Amyloid Pathology in Transgenic Mouse Models of Alzheimer's Disease.
Saul A; Wirths O
Mol Neurobiol; 2017 Jan; 54(1):319-327. PubMed ID: 26742512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
